ロード中...
Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
BACKGROUND: To evaluate the strategy for detection of prostate cancer (PCa) with low prostate specific antigen (PSA) level (2.5–4.0 ng/mL), prostate biopsy patients with low PSA were assessed. We evaluated the risk of low PSA PCa and the strategy for screening low-PSA patients. METHODS: We retrospec...
保存先:
| 出版年: | J Korean Med Sci |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Academy of Medical Sciences
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590649/ https://ncbi.nlm.nih.gov/pubmed/33107227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e342 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|